Overview

Condition traumatic brain injury
Sponsor Tampere University Hospital
Start date November 2015
End date October 2017
Trial size 100 participants
Trial identifier NCT01427959, R10027

Summary

Tampere Traumatic head and brain injury study is a prospective study aiming to explore neuroradiological, neuropsychological, neurological and biochemical aspects of mild traumatic brain injury (mtbi). The main interest is on factors that effect to the outcome after mtbi. The study is conducted in Tampere University Hospital's emergency department between the 1st of August 2010 and 31st of July 2013.

Recruiting in the following locations…

United States No locations recruiting
Other Countries Finland

Study Design

Observational model cohort
Time perspective prospective

Eligibility Criteria

Male or female participants from 18 years up to 60 years old.

Inclusion Criteria: - WHO's mtbi criteria - Inhabitant of Pirkanmaa hospital district - Age between 18 and 60 years Exclusion Criteria: - Detrimental alcohol use - Drug addiction - Chronic neurological disease - Earlier brain injury - Diagnosed psychiatric disease - Hearing or sight deficiency - Native language other than finnish

Additional Information

Official title Tampere Traumatic Head and Brain Injury Study
Principal investigator Teemu M. Luoto, M.D.
Description Aims of the study: 1. To improve clinical assessment of mTBI in the acute phase 2. To assemble better knowledge of diffusion tensor imaging as a diagnostic tool in mTBI 3. To improve neuropsychological evaluation of mTBI Main focus on psychosocial functioning / outcome / correlates E.g. Resilience, PTSD
Trial information was received from ClinicalTrials.gov and was last updated in October 2016.
Information provided to ClinicalTrials.gov by Tampere University Hospital.